| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, Amaal Bhaloo, Valerie Powell, Gary Remingto. Relationship between clinical improvement and functional gains with clozapine in schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 24. issue 10. 2015-07-14. PMID:25156578. |
relationship between clinical improvement and functional gains with clozapine in schizophrenia. |
2015-07-14 |
2023-08-13 |
human |
| Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, Amaal Bhaloo, Valerie Powell, Gary Remingto. Relationship between clinical improvement and functional gains with clozapine in schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 24. issue 10. 2015-07-14. PMID:25156578. |
we examined the relationship between change in symptoms and change in functioning in a group of patients with treatment-resistant schizophrenia after 6 and 12 weeks of clozapine treatment. |
2015-07-14 |
2023-08-13 |
human |
| S R T Veerman, P F J Schulte, M J H Begemann, L de Haa. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis. Pharmacopsychiatry. vol 47. issue 7. 2015-07-06. PMID:25121994. |
there is no convincing evidence regarding the efficacy of augmentation of clozapine with a second antipsychotic, ethyl eicosapentaenoic acid (e-epa), an antidepressant, a mood stabilizer or extract of ginkgo biloba in clozapine-resistant schizophrenia. |
2015-07-06 |
2023-08-13 |
Not clear |
| S R T Veerman, P F J Schulte, M J H Begemann, L de Haa. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis. Pharmacopsychiatry. vol 47. issue 7. 2015-07-06. PMID:25121994. |
we compared the effects of the addition of a second antipsychotic or an antidepressant to clozapine on positive, negative, overall and affective symptoms of schizophrenia in double-blind placebo-controlled trials. |
2015-07-06 |
2023-08-13 |
Not clear |
| Veeramanikandan Rajagopal, Lakshmikirupa Sundaresan, Anto P Rajkumar, Chithra Chittybabu, Anju Kuruvilla, Alok Srivastava, Poonkuzhali Balasubramanian, Kuruthukulangara S Jacob, Molly Jaco. Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea. Psychiatric genetics. vol 24. issue 6. 2015-06-25. PMID:25304228. |
ninety-five patients, mean age 35.43±9.43 years, with treatment-resistant schizophrenia and on clozapine were included in the study. |
2015-06-25 |
2023-08-13 |
Not clear |
| Paria Hebrani, Ali Akhoundpour Manteghi, Fatemeh Behdani, Elham Hessami, Kambiz Akhavan Rezayat, Majid Nabizadeh Marvast, Amir Akhavan Rezaya. Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. vol 20. issue 4. 2015-06-25. PMID:26109992. |
double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. |
2015-06-25 |
2023-08-13 |
Not clear |
| Paria Hebrani, Ali Akhoundpour Manteghi, Fatemeh Behdani, Elham Hessami, Kambiz Akhavan Rezayat, Majid Nabizadeh Marvast, Amir Akhavan Rezaya. Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. vol 20. issue 4. 2015-06-25. PMID:26109992. |
we aimed to investigate the effect of metformin as an adjunctive therapy with clozapine to prevent metabolic syndrome in patients with schizophrenia. |
2015-06-25 |
2023-08-13 |
Not clear |
| Ruohollah Seddigh, Somayeh Azarnik, Amir-Abbas Keshavarz-Akhlagh. Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review. Case reports in psychiatry. vol 2015. 2015-06-16. PMID:26078905. |
levothyroxine augmentation in clozapine resistant schizophrenia: a case report and review. |
2015-06-16 |
2023-08-13 |
Not clear |
| Ruohollah Seddigh, Somayeh Azarnik, Amir-Abbas Keshavarz-Akhlagh. Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review. Case reports in psychiatry. vol 2015. 2015-06-16. PMID:26078905. |
this case report outlines symptom subsidence of a patient with clozapine refractory paranoid schizophrenia and normal thyroid function who added levothyroxine to clozapine and found that symptoms of psychosis returned once levothyroxine was discontinued. |
2015-06-16 |
2023-08-13 |
Not clear |
| Mohammed Alawami, Cara Wasywich, Aleksandar Cicovic, Christopher Kened. A systematic review of clozapine induced cardiomyopathy. International journal of cardiology. vol 176. issue 2. 2015-06-15. PMID:25131906. |
clozapine is a unique anti-psychotic medication that is most effective in the treatment of refractory schizophrenia and reducing suicidality. |
2015-06-15 |
2023-08-13 |
human |
| Niko Seppälä, Esa Leinonen, Merja Viikki, Olli Kampma. Smoking and weight among patients using clozapine. Nordic journal of psychiatry. vol 68. issue 8. 2015-06-08. PMID:24802120. |
both obesity and smoking are common in schizophrenia patients taking clozapine, causing cardiovascular disease and premature deaths. |
2015-06-08 |
2023-08-13 |
Not clear |
| Minjie Ye, Wei Tang, Linjing Liu, Feixue Zhang, Jiahong Liu, Yuanling Chen, Da Chun Chen, Yun Long Tan, Fu De Yang, Mei Hong Xiu, Li Hui, Meng Han Lv, Jair C Soares, Xiang Yang Zhan. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. International clinical psychopharmacology. vol 29. issue 6. 2015-06-08. PMID:24803102. |
prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. |
2015-06-08 |
2023-08-13 |
Not clear |
| Minjie Ye, Wei Tang, Linjing Liu, Feixue Zhang, Jiahong Liu, Yuanling Chen, Da Chun Chen, Yun Long Tan, Fu De Yang, Mei Hong Xiu, Li Hui, Meng Han Lv, Jair C Soares, Xiang Yang Zhan. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. International clinical psychopharmacology. vol 29. issue 6. 2015-06-08. PMID:24803102. |
this study aimed to examine the prevalence and clinical associated variables of tardive dyskinesia (td) in a large sample of chinese inpatients with schizophrenia on long-term treatment with clozapine versus typical antipsychotics. |
2015-06-08 |
2023-08-13 |
Not clear |
| Minjie Ye, Wei Tang, Linjing Liu, Feixue Zhang, Jiahong Liu, Yuanling Chen, Da Chun Chen, Yun Long Tan, Fu De Yang, Mei Hong Xiu, Li Hui, Meng Han Lv, Jair C Soares, Xiang Yang Zhan. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. International clinical psychopharmacology. vol 29. issue 6. 2015-06-08. PMID:24803102. |
a total of 584 male inpatients with schizophrenia on long-term clozapine (n=341) or typical antipsychotic (n=243) treatment were evaluated using the abnormal involuntary movement scale (aims). |
2015-06-08 |
2023-08-13 |
Not clear |
| Minjie Ye, Wei Tang, Linjing Liu, Feixue Zhang, Jiahong Liu, Yuanling Chen, Da Chun Chen, Yun Long Tan, Fu De Yang, Mei Hong Xiu, Li Hui, Meng Han Lv, Jair C Soares, Xiang Yang Zhan. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. International clinical psychopharmacology. vol 29. issue 6. 2015-06-08. PMID:24803102. |
there are significant differences in the prevalence and clinical correlates of td in schizophrenia treated with clozapine versus typical antipsychotics. |
2015-06-08 |
2023-08-13 |
Not clear |
| Vicente Molina, Diana Taboada, María Aragüés, Juan A Hernández, Javier Sanz-Fuentenebr. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25088730. |
greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia. |
2015-05-26 |
2023-08-13 |
Not clear |
| Vicente Molina, Diana Taboada, María Aragüés, Juan A Hernández, Javier Sanz-Fuentenebr. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25088730. |
in this study we assessed the possible relation between cortical thickness in regions of interest selected because of previously reported structural alterations in schizophrenia and clinical and cognitive changes after two years of treatment with risperidone or clozapine in 31 neuroleptic-naïve fe patients with schizophrenia (16 of them treated with clozapine and 15 with risperidone). |
2015-05-26 |
2023-08-13 |
Not clear |
| Vicente Molina, Diana Taboada, María Aragüés, Juan A Hernández, Javier Sanz-Fuentenebr. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25088730. |
these results may support a positive predictive role for cortical thinning in the frontal region with regard to clinical and cognitive improvement with clozapine and risperidone in fe patients with schizophrenia. |
2015-05-26 |
2023-08-13 |
Not clear |
| Hidenaga Yamamori, Ryota Hashimoto, Yuko Fujita, Shusuke Numata, Yuka Yasuda, Michiko Fujimoto, Kazutaka Ohi, Satomi Umeda-Yano, Akira Ito, Tetsuro Ohmori, Kenji Hashimoto, Masatoshi Taked. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment. Neuroscience letters. vol 582. 2015-05-26. PMID:25218715. |
changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment. |
2015-05-26 |
2023-08-13 |
Not clear |
| Hidenaga Yamamori, Ryota Hashimoto, Yuko Fujita, Shusuke Numata, Yuka Yasuda, Michiko Fujimoto, Kazutaka Ohi, Satomi Umeda-Yano, Akira Ito, Tetsuro Ohmori, Kenji Hashimoto, Masatoshi Taked. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment. Neuroscience letters. vol 582. 2015-05-26. PMID:25218715. |
in this study, we examined whether peripheral nmda receptor-related glutamatergic amino acids levels were altered in patients with treatment-resistant schizophrenia compared to controls and whether these peripheral amino acids levels were altered by clozapine treatment. |
2015-05-26 |
2023-08-13 |
Not clear |